56P Continuation treatment with immunotherapy beyond two years in patients with metastasic non-small cell lung cancer: Retrospective analysis of optimal duration treatment.

Autor: Pellicer Boigues, A.V.¹ (AUTHOR), Garde Noguera, J.¹ (AUTHOR), Garcia Sanchez, J.¹ (AUTHOR), Piera, N.¹ (AUTHOR), Fenollosa Sanz, T.¹ (AUTHOR), Llor Rodriguez, P.¹ (AUTHOR), Iranzo Barreira, J.¹ (AUTHOR), Riquelme Cabrera, P.¹ (AUTHOR), Fernandez Murga Chavanne, M.L.¹ (AUTHOR), Llombart Cussac, A.¹ (AUTHOR)

Publikováno v: Annals of Oncology. 2021 Supplement 6, Vol. 32, pS1362-S1362. 1p.